Tap to find out a common medicine that can save you from COVID complications!
By Sharonya Kundu
New York: Researchers have declared that hospitalized COVID patients who were taking a daily dose of aspirin to guard against cardiovascular disease had a crucially low risk of complications and death. People who were taking aspirin were unlikely to be placed in the Intensive Care Unit (ICU) or chummed to a mechanical ventilator. They were more likely to get through the infection compared to those who were not taking aspirin.
According to the journal Anesthesia and Analgesia, cautious optimism for an affordable, accessible medication with a familiar safety profile that could help to stop severe complications. This is an evaluative discovery that needs to be confirmed through a randomized controlled trial. If the discovery is confirmed, it would make aspirin the first broadly accessible in the market to lessen the mortality in COVID-19 patients.
To perform the study, the research group examined the medical records of 412 COVID patients and averaged aged people who were hospitalized over the past few months due to complications of their contamination. Most of the patients were having a daily low-dose aspirin before they were admitted to the hospital or right after admission to control their cardiovascular disease. Doctors often suggest daily low-dose aspirin for patients who earlier had a heart attack caused by a blood clot to stop future blood clots. But daily use of aspirin can increase the chance of peptic ulcer or major bleeding diseases.